Sio Capital Management
Latest statistics and disclosures from Sio Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MESO, GLD, CHRS, MCK, JNJ, and represent 20.91% of Sio Capital Management's stock portfolio.
- Added to shares of these 10 stocks: MESO (+$17M), JNJ (+$17M), ALBO (+$16M), AMN (+$16M), BMRN (+$15M), CI (+$14M), HZNP (+$12M), CVM (+$11M), HRC (+$9.2M), CAH (+$8.9M).
- Started 33 new stock positions in EPIX, OYST, MDT, HZNP, ZSAN, Pmv Pharmaceuticals, DGX, Goodrx Hldgs, CRBP, ODT.
- Reduced shares in these 10 stocks: , RCM (-$8.5M), CBAY (-$8.3M), LLY (-$7.5M), , GWPH (-$7.3M), BMY.R (-$6.2M), , IMAB, ANTM.
- Sold out of its positions in Actinium Pharmaceuticals, ARAV, BLCM, BIIB, BSX, BMY.R, FUSN, IMVT, INGN, KDMN. LLY, MRK, NERV, MORF, OSUR, PGNY, RCM, STRO, TRIL, VAPO, ZYNE.
- Sio Capital Management was a net buyer of stock by $158M.
- Sio Capital Management has $505M in assets under management (AUM), dropping by 47.37%.
Tip: Access up to 7 years of quarterly data
Positions held by Sio Capital Management, LLC consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sio Capital Management
Companies in the Sio Capital Management portfolio as of the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Mesoblast Spons Adr Put Option (MESO) | 5.8 | $29M | +143% | 1.6M | 18.59 | |
| Spdr Gold Shares Gold Shs (GLD) | 4.5 | $23M | +6% | 128k | 177.12 | |
| Coherus Biosciences (CHRS) | 3.8 | $19M | -8% | 1.0M | 18.34 | |
| McKesson Corporation (MCK) | 3.5 | $18M | +21% | 118k | 148.93 | |
| Johnson & Johnson (JNJ) | 3.4 | $17M | NEW | 114k | 148.88 | |
| Hill-Rom Holdings (HRC) | 3.3 | $17M | +122% | 200k | 83.51 | |
| Albireo Pharma (ALBO) | 3.2 | $16M | NEW | 479k | 33.37 | |
| AMN Healthcare Services (AMN) | 3.2 | $16M | NEW | 272k | 58.46 | |
| AmerisourceBergen (ABC) | 3.1 | $16M | +62% | 164k | 96.92 | |
| Cel-sci Corp Com Par New Put Option (CVM) | 3.0 | $15M | +261% | 1.2M | 12.75 | |
| Cardinal Health (CAH) | 3.0 | $15M | +141% | 323k | 46.95 | |
| BioMarin Pharmaceutical (BMRN) | 2.9 | $15M | NEW | 195k | 76.08 | |
| Cigna Corp (CI) | 2.7 | $14M | NEW | 81k | 169.42 | |
| Hca Holdings (HCA) | 2.6 | $13M | +29% | 106k | 124.68 | |
Setup an alertSio Capital Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Molina Healthcare (MOH) | 2.4 | $12M | +15% | 66k | 183.04 | |
| Horizon Therapeutics SHS (HZNP) | 2.3 | $12M | NEW | 148k | 77.68 | |
| Walgreen Boots Alliance (WBA) | 2.1 | $11M | +141% | 300k | 35.92 | |
| Seres Therapeutics Put Option (MCRB) | 1.8 | $9.0M | +470% | 317k | 28.31 | |
| Quest Diagnostics Incorporated (DGX) | 1.7 | $8.6M | NEW | 75k | 114.49 | |
| Teva Pharmaceutical Industries Sponsored Ads (TEVA) | 1.7 | $8.6M | 952k | 9.01 | ||
| Cymabay Therapeutics (CBAY) | 1.7 | $8.4M | -49% | 1.2M | 7.24 | |
| Radius Health Com New (RDUS) | 1.6 | $7.9M | +91% | 695k | 11.34 | |
| Soliton (SOLY) | 1.6 | $7.8M | 1.0M | 7.64 | ||
| Glaxosmithkline Sponsored Adr (GSK) | 1.5 | $7.8M | NEW | 207k | 37.64 | |
| Integer Hldgs (ITGR) | 1.5 | $7.6M | NEW | 129k | 59.01 | |
| Viewray (VRAY) | 1.4 | $7.1M | +57% | 2.0M | 3.50 | |
| Orthofix Medical (OFIX) | 1.3 | $6.8M | +13% | 218k | 31.14 | |
| United Therapeutics Corporation (UTHR) | 1.2 | $6.0M | -9% | 59k | 101.00 | |
| Syneos Health Cl A (SYNH) | 1.2 | $5.9M | NEW | 111k | 53.16 | |
| Curis Com New (CRIS) | 1.1 | $5.8M | +15% | 5.0M | 1.17 | |
| Kodiak Sciences (KOD) | 1.1 | $5.5M | +347% | 92k | 59.21 | |
| Mersana Therapeutics (MRSN) | 1.1 | $5.4M | -21% | 292k | 18.62 | |
| Arena Pharmaceuticals Com New (ARNA) | 1.1 | $5.4M | -24% | 72k | 74.78 | |
| Cardiovascular Systems (CSII) | 1.0 | $4.9M | NEW | 125k | 39.35 | |
| Larimar Therapeutics (LRMR) | 0.9 | $4.6M | -5% | 301k | 15.17 | |
| Essa Pharma Com New (EPIX) | 0.9 | $4.5M | NEW | 656k | 6.90 | |
| Anthem (ANTM) | 0.9 | $4.3M | -49% | 16k | 268.60 | |
| Chardan Healthcare Acquisition 2 Corp Unit (CHAQ.U) | 0.8 | $4.2M | 400k | 10.55 | ||
| Quanterix Ord (QTRX) | 0.8 | $4.2M | -14% | 125k | 33.74 | |
| Herbalife Nutrition Com Shs (HLF) | 0.8 | $4.1M | NEW | 89k | 46.65 | |
| Viking Therapeutics (VKTX) | 0.8 | $4.1M | 710k | 5.82 | ||
| Medtronic SHS (MDT) | 0.8 | $4.1M | NEW | 39k | 103.92 | |
| Ardelyx (ARDX) | 0.8 | $4.0M | +25% | 754k | 5.25 | |
| Becton, Dickinson and (BDX) | 0.8 | $3.9M | NEW | 17k | 232.67 | |
| RadNet (RDNT) | 0.7 | $3.4M | +65% | 224k | 15.35 | |
| Anika Therapeutics (ANIK) | 0.7 | $3.3M | +161% | 94k | 35.39 | |
| Affimed Therapeutics B V (AFMD) | 0.6 | $3.1M | -2% | 911k | 3.39 | |
| Leap Therapeutics (LPTX) | 0.6 | $2.9M | -3% | 1.5M | 1.98 | |
| Lifesci Acquisition Corp Unit 03/31/2025 (LSACU) | 0.6 | $2.9M | 210k | 13.60 | ||
| Health Sciences Acquisitions Corporation 2 Ord Shs | 0.5 | $2.8M | NEW | 250k | 11.00 | |
| Aslan Pharmaceuticals Ads (ASLN) | 0.5 | $2.6M | 1.4M | 1.90 | ||
| Cross Country Healthcare (CCRN) | 0.5 | $2.6M | NEW | 401k | 6.49 | |
| Cerecor (CERC) | 0.5 | $2.3M | +3% | 1.0M | 2.27 | |
| Neubase Therapeutics Ord (NBSE) | 0.5 | $2.3M | +69% | 304k | 7.59 | |
| Esperion Therapeutics (ESPR) | 0.5 | $2.3M | 62k | 37.18 | ||
| Oyster Point Pharma (OYST) | 0.4 | $2.2M | NEW | 106k | 21.11 | |
| Precision Biosciences Ord (DTIL) | 0.4 | $2.2M | +92% | 356k | 6.16 | |
| Vanda Pharmaceuticals (VNDA) | 0.4 | $2.0M | +45% | 209k | 9.66 | |
| Gw Pharmaceuticals Ads (GWPH) | 0.4 | $2.0M | -78% | 21k | 97.36 | |
| Agios Pharmaceuticals (AGIO) | 0.4 | $2.0M | NEW | 56k | 35.00 | |
| Ayala Pharmaceuticals Incorporated (AYLA) | 0.4 | $1.8M | +39% | 160k | 11.52 | |
| Actinium Pharmaceuticals | 0.4 | $1.8M | NEW | 189k | 9.69 | |
| Odonate Therapeutics Ord (ODT) | 0.4 | $1.8M | NEW | 135k | 13.43 | |
| Natus Medical (NTUS) | 0.4 | $1.8M | NEW | 104k | 17.13 | |
| Cellectar Biosciences Com Par (CLRB) | 0.3 | $1.7M | +620% | 1.4M | 1.24 | |
| Dyadic International (DYAI) | 0.3 | $1.6M | 209k | 7.57 | ||
| Aeglea Biotherapeutics (AGLE) | 0.3 | $1.5M | 211k | 7.09 | ||
| Syros Pharmaceuticals (SYRS) | 0.3 | $1.5M | -38% | 167k | 8.84 | |
| Varex Imaging (VREX) | 0.3 | $1.5M | NEW | 115k | 12.72 | |
| Mei Pharma Com New (MEIP) | 0.3 | $1.4M | +832% | 448k | 3.12 | |
| Harrow Health (HROW) | 0.3 | $1.3M | 239k | 5.59 | ||
| Atreca Cl A Com (BCEL) | 0.2 | $1.1M | +265% | 79k | 13.97 | |
| Corbus Pharmaceuticals Hldgs Put Option (CRBP) | 0.2 | $1.0M | NEW | 556k | 1.80 | |
| Alpha Healthcare Acquisition Corp Unit 09/21/2027 | 0.2 | $992k | NEW | 100k | 9.92 | |
| Kura Oncology (KURA) | 0.2 | $959k | -26% | 31k | 30.66 | |
| Catalyst Biosciences Com New (CBIO) | 0.2 | $854k | 199k | 4.30 | ||
| Zosano Pharma Corp Com New (ZSAN) | 0.1 | $733k | NEW | 453k | 1.62 | |
| I-mab Sponsored Ads (IMAB) | 0.1 | $705k | -87% | 15k | 47.00 | |
| Ideaya Biosciences (IDYA) | 0.1 | $691k | 55k | 12.56 | ||
| Deerfield Healthcare Technology Acquisitions Corp Unit 07/16/2025 | 0.1 | $532k | NEW | 50k | 10.64 | |
| Neoleukin Therapeutics (NLTX) | 0.1 | $460k | 38k | 12.01 | ||
| Rapt Therapeutics (RAPT) | 0.1 | $460k | 14k | 32.17 | ||
| Casi Pharmaceuticalsinc Com Stk (CASI) | 0.1 | $344k | NEW | 225k | 1.53 | |
| Panacea Acquisition Corp Unit | 0.0 | $180k | NEW | 15k | 12.00 | |
| Bionano Genomics (BNGO) | 0.0 | $174k | -82% | 268k | 0.65 | |
| Myovant Sciences (MYOV) | 0.0 | $142k | NEW | 10k | 14.06 | |
| Syndax Pharmaceuticals (SNDX) | 0.0 | $71k | NEW | 4.8k | 14.80 | |
| Goodrx Holdings Com Cl A | 0.0 | $56k | NEW | 1.0k | 56.00 | |
| Pmv Pharmaceuticals | 0.0 | $36k | NEW | 1.0k | 36.00 | |
Past Filings by Sio Capital Management
SEC 13F filings are viewable for Sio Capital Management going back to 2010
- Sio Capital Management 2020 Q3 filed Nov. 16, 2020
- Sio Capital Management 2020 Q2 filed Aug. 14, 2020
- Sio Capital Management 2020 Q1 filed May 15, 2020
- Sio Capital Management 2019 Q4 filed Feb. 14, 2020
- Sio Capital Management 2019 Q3 filed Nov. 14, 2019
- Sio Capital Management 2019 Q2 filed Aug. 14, 2019
- Sio Capital Management 2019 Q1 filed May 15, 2019
- Sio Capital Management 2018 Q4 filed Feb. 14, 2019
- Sio Capital Management 2018 Q3 filed Nov. 14, 2018
- Sio Capital Management 2018 Q2 filed Aug. 14, 2018
- Sio Capital Management 2018 Q1 filed May 15, 2018
- Sio Capital Management 2017 Q4 filed Feb. 14, 2018
- Sio Capital Management 2017 Q3 filed Nov. 14, 2017
- Sio Capital Management 2017 Q2 filed Aug. 14, 2017
- Sio Capital Management 2017 Q1 filed May 15, 2017
- Sio Capital Management 2016 Q4 filed Feb. 14, 2017